Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer Disease: A Truncated Randomized Phase 2b/3 Clinical Trial. uri icon

authors

  • Reisa Sperling, MD
  • Karcher, Keith
  • Raghavan, Nandini
  • Tymofyeyev, Yevgen
  • Bogert, Jennifer
  • Brashear, H Robert
  • Novak, Gerald
  • Thipphawong, John
  • Saad, Ziad S
  • Kolb, Hartmuth
  • Rofael, Hany
  • Henley, David
  • Sanga, Panna
  • Romano, Gary
  • Aisen, Paul S
  • Raman, Rema
  • Donohue, Michael C
  • Ernstrom, Karin
  • Rafii, Michael S
  • Streffer, Johannes
  • Shi, Yingqi

publication date

  • January 1, 2021